Anti-Infective Drugs Global Market Report 2018

Starting Price : $ 4000.00 | Pages : 125 | Published : February 2018 | SKU CODE : 3255 | Format :

Infectious diseases are disorders caused by several pathogenic organisms such as bacteria, viruses, fungi or parasites. These diseases can be transmitted or spread from one person to another through direct contact or indirect contact. Anti-infective drugs are used to treat or prevent these infectious diseases by inhibiting the spread of an infectious agent (static) or by killing the infectious agent (cidal).

The global anti-infective drugs market was valued at around $117 billion in 2017. North America was the largest region in the anti-infective drugs market in 2017, accounting for 30% market share. The USA was the largest country in the market in 2017, accounting for nearly 25% market share.
Companies in the anti-infective drugs market are working towards constant innovation to provide more effective drugs and also to sustain in the competition of the market. The FDA approved 22 new drugs in 2016. Among them, drugs for infectious diseases held the largest share with 40% (9) approvals. Recently approved antibiotic drugs include Descovy from Gilead Lifesciences, Zepatier from Merck & Co. and others.

The top five companies covered are Gilead Sciences Inc., Merck & Co., GlaxosmithKline Plc., Bristol-Myers Squibb Company and Johnson & Johnson. Gilead was the largest competitor in the anti-infective drugs market in 2017.

The countries covered are USA, China, Germany, Brazil, Japan, UK, Spain, Russia, France, Australia, Italy, India and rest of the world.

The anti infective drugs market is segmented into Antiviral Drugs, Antibacterial Drugs/Antibiotic Drugs, Antifungal Drugs and Antiparasitic Drugs.
Antiviral Drugs are used to treat viral infections. These drugs are classified into anti-herpes virus agents, anti-influenza agents, antiretroviral agents, anti-hepatitis agents and other antiviral agents.
Antibacterial Drugs/Antibiotic Drugs are used to treat or prevent the bacterial infections. They may kill or inhibit the growth of bacteria.
Antifungal Drugs are used to treat fungal infections. These drugs can be classified into azole derivatives including fluconazole, itraconazole, ketoconazole, polyene antibiotics including amphotericin B, nystatin, allylamine drugs including terbinafine, nafitifine and echinocandin drugs including caspofungin, micafungin, anidulafungin.
Antiparasitic Drugs are used to treat infections caused by parasites. These can be classified into antiprotozoal, antimalarial, antihelminthic and ectoparasiticide drugs.

Over 1000 Biologics Under Development Will Drive The Biologics Market To 10% Yearly Growth

Public Policy Restrains Blood Glucose Test Strips Market Growth

The Leading Players In The Cardiovascular Devices Market Are Innovating To Stay Ahead

India Is The World’s Fastest-Growing Market For In-Vitro Diagnostics

Lower Average Prices Will Affect Global Market For Blood Glucose Test Strips

Neurology Devices Are Replacing Drugs As First Treatment Preference

Eastern Europe Is The Fastest-Growing Region For The Cancer Drugs Market

Increased Pet Ownership Drives Veterinary Services Market Growth

Veterinary Services Global Market Report 2018

View Report

Blood Glucose Test Strips Global Market Report 2018

View Report

Nephrology And Urology Devices Market Global Briefing 2018

View Report

Neurology Devices Market Global Briefing 2018

View Report

ENT Devices Market Global Briefing 2018

View Report

Orthopedic Devices Market Global Briefing 2018

View Report

Wound Care Devices Market Global Briefing 2018

View Report

Diabetes Care Devices Market Global Briefing 2018

View Report

Call Us

+1 3156230293

(Americas)

+44 2071930708

(Europe)

+91 8897263534

(Asia & Others)